Adult T-cell leukemia risk factors: Difference between revisions
Jump to navigation
Jump to search
(Category) |
|||
| Line 31: | Line 31: | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Revision as of 02:53, 24 October 2017
|
Adult T-cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adult T-cell leukemia risk factors On the Web |
|
American Roentgen Ray Society Images of Adult T-cell leukemia risk factors |
|
Risk calculators and risk factors for Adult T-cell leukemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Common risk factors in the development of adult T-cell leukemia among HTLV carriers are vertical transmission of HTLV infection during infancy, male sex, and specific human leukocyte antigens such as HLA-A 26, HLA-B 4002, and HLA-B 4801.[1]
Risk Factors
- Vertical transmission of HTLV infection during infancy
- Male sex
- Specific human leukocyte antigens such as:
- Patients with a Strongyloides stercoralis co-infection
- An elevated soluble interleukin-2 receptor levels (> 500 U/ml)
- An elevated anti-HTLV-1 antibody titer
- An elevated HTLV proviral load level (> 4 copies per 100 peripheral blood mononuclear cells)
- An elevated WBC count (> 9,000/μL)
- An elevated abnormal lymphocyte count
- A decreased level of anti-Tax reactivity
References
- ↑ 1.0 1.1 Iwanaga M, Watanabe T, Yamaguchi K (2012). "Adult T-cell leukemia: a review of epidemiological evidence". Front Microbiol. 3: 322. doi:10.3389/fmicb.2012.00322. PMC 3437524. PMID 22973265.